![John Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Henderson
Vorsitzender bei
CYTOKINETICS, INCORPORATED
Vermögen: 6 Mio $ am 31.05.2026
Profil
John Tannahill Henderson is Chairman at Cytokinetics, Inc. since 2022, with employment at the firm starting in 2009.
Former roles include Chairman at Asmacure Ltée; Independent Director at Myriad Genetics, Inc. in 2020; Non-Executive Director at Inveresk Research Group, Inc.; Independent Director at Myrexis, Inc. from 2011 to 2013; Vice President at Pfizer Pharmaceuticals, Inc.; President at Futurepharm LLC; Chief Development Officer at NeuroVia, Inc.; and VP-Europe, US & International Pharmaceuticals at Pfizer Inc. Education includes undergraduate and doctorate degrees from The University of Edinburgh.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 78 171 ( 0,06 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von John Henderson
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Vorsitzender | 08.04.2022 |
Ehemalige bekannte Positionen von John Henderson
| Unternehmen | Position | Ende |
|---|---|---|
| MYRIAD GENETICS, INC. | Vorsitzender | 23.03.2020 |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Corporate Officer/Principal | 01.10.2018 |
| MYREXIS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.12.2000 |
| PFIZER INC. | Corporate Officer/Principal | 01.12.2000 |
Ausbildung von John Henderson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
Wählen Sie MarketScreener 
